Get started
Work

CCK2Receptor Ligand [68Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [68Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung Cancer

Year: 2025
Type: article
Study design: Case Report
Abstract: Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers and is characterized by an exceptionally high proliferative rate, a strong tendency for early metastasis, and a poor prognosis ([1][1]). Cholecystokinin-2 receptor (CCK2R) is overexpressed in more than half of SCLC
DOI: 10.2967/jnumed.124.269201
Authors: Oliver Viering, Nadine Holzleitner, Rainer Claus, Adriana Amerein, Niklas Dreher, Johanna S. Enke, Alexander Dierks, Christian H. Pfob, Malte Kircher, Veronika Felber, Thomas Günther, Constantin Lapa
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4407765639
FWCI: 1.209
Cites: 5
Cited by: 2
Related to: 10